guest ::
| Home > Publications Database > P02.01.B 3-PHOTON IN VIVO IMAGING REVEALS BREAKDOWN OF MICROGLIA SURVEILLANCE UPON GLIOMA INVASION IN THE CORPUS CALLOSUM > print |
| Home > Publications Database > P02.01.B 3-PHOTON IN VIVO IMAGING REVEALS BREAKDOWN OF MICROGLIA SURVEILLANCE UPON GLIOMA INVASION IN THE CORPUS CALLOSUM > print |
| 001 | 272832 | ||
| 005 | 20241028164614.0 | ||
| 024 | 7 | _ | |a 10.1093/neuonc/noae144.104 |2 doi |
| 024 | 7 | _ | |a 1522-8517 |2 ISSN |
| 024 | 7 | _ | |a 1523-5866 |2 ISSN |
| 037 | _ | _ | |a DZNE-2024-01250 |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Nebeling, F. C. |0 P:(DE-2719)2811414 |b 0 |e First author |u dzne |
| 111 | 2 | _ | |a 19th Meeting of the European Association of Neuro-Oncology |g EANO 2024 |c Glasgow |d 2024-10-17 - 2024-10-20 |w UK |
| 245 | _ | _ | |a P02.01.B 3-PHOTON IN VIVO IMAGING REVEALS BREAKDOWN OF MICROGLIA SURVEILLANCE UPON GLIOMA INVASION IN THE CORPUS CALLOSUM |
| 260 | _ | _ | |a Oxford |c 2024 |b Oxford Univ. Press |
| 300 | _ | _ | |a v34 |
| 336 | 7 | _ | |a CONFERENCE_PAPER |2 ORCID |
| 336 | 7 | _ | |a Conference Paper |0 33 |2 EndNote |
| 336 | 7 | _ | |a Journal Article |0 PUB:(DE-HGF)16 |2 PUB:(DE-HGF) |m journal |
| 336 | 7 | _ | |a INPROCEEDINGS |2 BibTeX |
| 336 | 7 | _ | |a conferenceObject |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Conference Paper |2 DataCite |
| 336 | 7 | _ | |a Contribution to a conference proceedings |b contrib |m contrib |0 PUB:(DE-HGF)8 |s 1730118870_18936 |2 PUB:(DE-HGF) |
| 536 | _ | _ | |a 352 - Disease Mechanisms (POF4-352) |0 G:(DE-HGF)POF4-352 |c POF4-352 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, Journals: pub.dzne.de |
| 700 | 1 | _ | |a Fuhrmann, F. |0 P:(DE-2719)2811225 |b 1 |u dzne |
| 700 | 1 | _ | |a Mittag, M. |0 P:(DE-2719)2811044 |b 2 |u dzne |
| 700 | 1 | _ | |a Deli, A. |0 P:(DE-HGF)0 |b 3 |
| 700 | 1 | _ | |a Stork, M. |0 P:(DE-2719)2810452 |b 4 |u dzne |
| 700 | 1 | _ | |a Clements, M. |b 5 |
| 700 | 1 | _ | |a Garcia Diaz, C. |b 6 |
| 700 | 1 | _ | |a Parrinello, S. |b 7 |
| 700 | 1 | _ | |a Hölzel, M. |b 8 |
| 700 | 1 | _ | |a Herrlinger, U. |b 9 |
| 700 | 1 | _ | |a Salomoni, P. |0 P:(DE-2719)2811779 |b 10 |u dzne |
| 700 | 1 | _ | |a Fuhrmann, M. |0 P:(DE-2719)2679991 |b 11 |e Last author |u dzne |
| 773 | _ | _ | |a 10.1093/neuonc/noae144.104 |g Vol. 26, no. Supplement_5, p. v34 - v34 |0 PERI:(DE-600)2094060-9 |n Supplement_5 |p v34 |t Neuro-Oncology |v 26 |y 2024 |x 1522-8517 |
| 856 | 4 | _ | |u https://pub.dzne.de/record/272832/files/DZNE-2024-01250_Restricted.pdf |
| 856 | 4 | _ | |u https://pub.dzne.de/record/272832/files/DZNE-2024-01250_Restricted.pdf?subformat=pdfa |x pdfa |
| 909 | C | O | |o oai:pub.dzne.de:272832 |p VDB |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 0 |6 P:(DE-2719)2811414 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 1 |6 P:(DE-2719)2811225 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 2 |6 P:(DE-2719)2811044 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 3 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 4 |6 P:(DE-2719)2810452 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 10 |6 P:(DE-2719)2811779 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 11 |6 P:(DE-2719)2679991 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-352 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Disease Mechanisms |x 0 |
| 914 | 1 | _ | |y 2024 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2023-10-24 |w ger |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b NEURO-ONCOLOGY : 2022 |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-24 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2023-10-24 |
| 915 | _ | _ | |a IF >= 15 |0 StatID:(DE-HGF)9915 |2 StatID |b NEURO-ONCOLOGY : 2022 |d 2023-10-24 |
| 920 | 1 | _ | |0 I:(DE-2719)1011004 |k AG Fuhrmann |l Neuroimmunology and Imaging |x 0 |
| 920 | 1 | _ | |0 I:(DE-2719)1013032 |k AG Salomoni |l Nuclear Function in CNS Pathophysiology |x 1 |
| 980 | _ | _ | |a contrib |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a I:(DE-2719)1011004 |
| 980 | _ | _ | |a I:(DE-2719)1013032 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|